Site intended for UK audience


Trigelan® contains the three active substances levodopa, carbidopa and entacapone in one film-coated tablet.

Trigelan® is a medicine used to treat Parkinson’s disease.

Parkinson’s is caused by a deficiency of the neurotransmitter dopamine in the brain. Levodopa increases the amount of dopamine and thus reduces the symptoms of Parkinson’s disease. Carbidopa and entacapone improve the antiparkinsonian effects of levodopa.

Active substance: Levodopa, Carbidopa, Entacapone

Strength Pack size
50 mg/12,5 mg/200 mg 30, 100
100 mg/25 mg/200 mg 30, 100
150 mg/37,5 mg/200 mg 30, 100
200 mg/50 mg/200 mg 30, 100

Physicians / Pharmacists Login

We ask for your understanding that due to the Austrian Medicines Act, certain further information is only accessible to medical professionals.

Login Physicians / Pharmacists Login